{
  "id": 16972855,
  "title": "Replimune (REPL) Q2 2027 Earnings Call Transcript",
  "url": "https://urgent.news/2026/10/28/replimune-repl-q2-2027-earnings-call-transcript",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-28T22:24:47.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/earnings/call-transcripts/2026/10/28/replimune-repl-q2-2027-earnings-call-transcript/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": null,
  "summary": "TUDRIQEV launched with $450,000 price tag and early traction across oncology institutions.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Replimune (REPL) Q2 2027 Earnings Call Transcript",
        "url": "https://urgent.news/2026/10/28/replimune-repl-q2-2027-earnings-call-transcript-16974046",
        "published": "2026-10-28T22:44:47.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}